Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438932 · ClinicalTrials.gov registry record · NA
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00438932: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00438932 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438932, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients with chronic kidney disease.
Primary Outcome
Plasma FGF-23 was measured using c-terminal FGF23 assay.
Interventions
- DRUG Placebo
- DRUG Lanthanum Carbonate
- DIETARY_SUPPLEMENT Low Phosphorus Diet
- DIETARY_SUPPLEMENT Unrestricted Phosphorus Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-01 |
| Phase | NA |
What the finished NCT00438932 record still lists
NCT00438932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00438932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00438932 about?
NCT00438932 is a clinical study titled "Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease". The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients wit...
What is the current status of trial NCT00438932?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-01. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00438932?
The interventions under investigation include: Placebo (DRUG), Lanthanum Carbonate (DRUG), Low Phosphorus Diet (DIETARY_SUPPLEMENT), Unrestricted Phosphorus Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00438932?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00438932's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia